{'objectFormulation': '', 'drug1rxc': 'http://purl.bioontology.org/ontology/RXNORM/0', 'suffix': '', 'cl': '', 'drug2Role': 'dikbD2R:object-drug-of-interaction', 'cmaxType': '', 'prefix': 's) when given usual doses. Depending on the fraction of drug metabolized by P450 2D6, the increase in plasma concentration may be small, or quite large (8-fold increase in plasma AUC of the TCA ).  ', 'modality': 'ncit:positive', 'drug2rxc': 'http://purl.bioontology.org/ontology/RXNORM/', 'drug2Lab': 'TCA', 'auc': '', 'clDirection': '', 'drug1Lab': 'phenothiazines', 'source': 'http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/ea35caf8-c8c8-481a-97a2-25f68cbc240b.html', 't12': '', 'aucDirection': '', 't12Direction': '', 'clType': '', 't12Type': '', 'drug1Type': 'dikbD2R:drug-group', 'numOfParticipants': '', 'statementType': 'ncit:Qualitative', 'objectRegimens': '', 'drug2Type': 'dikbD2R:drug-group', 'aucType': '', 'exactText': 'In addition, certain drugs inhibit the activity of this isozyme and make normal metabolizers resemble poor metabolizers. An individual who is stable on a given dose of TCA may become abruptly toxic when given one of these inhibiting drugs as concomitant therapy. The drugs that inhibit cytochrome P450 2D6 include some that are not metabolized by the enzyme (quinidine; cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the Type 1C antiarrhythmics propafenone and flecainide). While all the selective serotonin reuptake inhibitors (SSRIs), e.g., fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition. The extent to which SSRI-TCA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved. Nevertheless, caution is indicated in the coadministration of TCAs with any of the SSRIs and also in switching from one class to the other. Of particular importance, sufficient time must elapse before initiating TCA treatment in a patient being withdrawn from fluoxetine, given the long half-life of the parent and active metabolite (at least 5 weeks may be necessary).', 'dose1': '', 'dose2': '', 'date': '2015-09-29 09:04:36 -0400', 'cmaxDirection': '', 'assertionType': 'drug-drug-interaction', 'drug1Role': 'dikbD2R:precipitant-drug-of-interaction', 'preciptFormulation': '', 'preciptDuration': '', 'objectDuration': '', 'evidenceType': 'evidence-supports', 'preciptRegimens': '', 'cmax': ''}
{u'@id': 'urn:domeoclient:uuid:36078e63-29b7-40a2-9f6a-06e220e8b972',
 u'@type': u'ao:AnnotationSet',
 u'ao_!DOMEO_NS!_annotatesResource': 'http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/ea35caf8-c8c8-481a-97a2-25f68cbc240b.html',
 u'ao_!DOMEO_NS!_item': [{u'@id': 'urn:domeoclient:uuid:3ec34423-b4bb-4532-833c-08ef413d4189',
                          u'@type': u'ao:ddiAnnotation',
                          u'ao_!DOMEO_NS!_body': [{u'sets': {u'@id': 'urn:pddi:uuid:14508c5f-6e1e-40a6-a970-2b161e589d8c',
                                                             u'@type': u'poc:DrugDrugInteractionStatement',
                                                             u'dikbD2R_!DOMEO_NS!_modality': 'ncit:positive',
                                                             u'dikbD2R_!DOMEO_NS!_statement': 'ncit:Qualitative',
                                                             u'sio_!DOMEO_NS!_SIO_000205': u'dikbD2R:statement',
                                                             u'sio_!DOMEO_NS!_SIO_000563': u'dikbD2R:modality',
                                                             u'sio_!DOMEO_NS!_SIO_000628': [{u'@id': 'urn:pddi:uuid:3cb49aa9-dc58-4297-87ee-ea7a46047a3b',
                                                                                             u'@type': u'dikbD2R:PK_DDI',
                                                                                             u'dikbD2R_!DOMEO_NS!_auc': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_aucDirection': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_aucType': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_cl': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_clDirection': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_clType': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_cmax': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_cmaxDirection': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_cmaxType': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_numOfParticipants': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_objectDuration': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_objectFormulation': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_objectRegimens': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_preciptDuration': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_preciptFormulation': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_preciptRegimens': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_t12': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_t12Direction': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_t12Type': '',
                                                                                             u'sio_!DOMEO_NS!_SIO_000132': [{u'@id': '0e9d145f-2c72-4d85-9009-53e05f24c1c0',
                                                                                                                             u'@type': 'dikbD2R:drug-group',
                                                                                                                             u'dailymed_!DOMEO_NS!_activeMoietyRxCUI': 'http://purl.bioontology.org/ontology/RXNORM/0',
                                                                                                                             u'dct_!DOMEO_NS!_description': u'Referred to the drug in the interaction.',
                                                                                                                             u'dikbD2R_!DOMEO_NS!_dose': '',
                                                                                                                             u'rdfs_!DOMEO_NS!_label': 'phenothiazines',
                                                                                                                             u'sio_!DOMEO_NS!_SIO_000228': 'dikbD2R:precipitant-drug-of-interaction'},
                                                                                                                            {u'@id': '8fc2e7cf-ce30-4fac-ab77-ec4f0907d1c6',
                                                                                                                             u'@type': 'dikbD2R:drug-group',
                                                                                                                             u'dailymed_!DOMEO_NS!_activeMoietyRxCUI': 'http://purl.bioontology.org/ontology/RXNORM/',
                                                                                                                             u'dct_!DOMEO_NS!_description': u'Referred to the drug in the interaction.',
                                                                                                                             u'dikbD2R_!DOMEO_NS!_dose': '',
                                                                                                                             u'rdfs_!DOMEO_NS!_label': 'TCA',
                                                                                                                             u'sio_!DOMEO_NS!_SIO_000228': 'dikbD2R:object-drug-of-interaction'}]}]}}],
                          u'ao_!DOMEO_NS!_context': [{u'@id': 'urn:domeoclient:uuid:a14bba75-ffce-46ce-b063-a57b716b5f5d',
                                                      u'@type': u'ao:SpecificResource',
                                                      u'ao_!DOMEO_NS!_hasSelector': {u'@id': 'urn:domeoclient:uuid:4c9c9ff8-75e1-4e4c-966f-5d9383c18770',
                                                                                     u'@type': u'ao:PrefixSuffixTextSelector',
                                                                                     u'ao_!DOMEO_NS!_exact': 'In addition, certain drugs inhibit the activity of this isozyme and make normal metabolizers resemble poor metabolizers. An individual who is stable on a given dose of TCA may become abruptly toxic when given one of these inhibiting drugs as concomitant therapy. The drugs that inhibit cytochrome P450 2D6 include some that are not metabolized by the enzyme (quinidine; cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the Type 1C antiarrhythmics propafenone and flecainide). While all the selective serotonin reuptake inhibitors (SSRIs), e.g., fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition. The extent to which SSRI-TCA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved. Nevertheless, caution is indicated in the coadministration of TCAs with any of the SSRIs and also in switching from one class to the other. Of particular importance, sufficient time must elapse before initiating TCA treatment in a patient being withdrawn from fluoxetine, given the long half-life of the parent and active metabolite (at least 5 weeks may be necessary).',
                                                                                     u'ao_!DOMEO_NS!_prefix': 'e in plasma AUC of the TCA ).  ',
                                                                                     u'ao_!DOMEO_NS!_suffix': '',
                                                                                     u'domeo_!DOMEO_NS!_uuid': 'e0d74001-11c2-4d78-aa1c-4579377d193e',
                                                                                     u'domeo_temp_localId': u'1',
                                                                                     u'pav_!DOMEO_NS!_createdOn': '2015-09-29 09:04:36 -0400'},
                                                      u'ao_!DOMEO_NS!_hasSource': 'http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/ea35caf8-c8c8-481a-97a2-25f68cbc240b.html',
                                                      u'domeo_temp_localId': u'1'}],
                          u'dikbD2R_!DOMEO_NS!_assertionType': 'drug-drug-interaction',
                          u'dikbD2R_!DOMEO_NS!_evidenceType': u'evidence-challenges',
                          u'domeo_!DOMEO_NS!_belongsToSet': 'urn:domeoclient:uuid:36078e63-29b7-40a2-9f6a-06e220e8b972',
                          u'pav_!DOMEO_NS!_createdBy': 'urn:person:uuid:ff808181508ae86901508ae930ec0000',
                          u'pav_!DOMEO_NS!_createdOn': '2015-09-29 09:04:36 -0400',
                          u'pav_!DOMEO_NS!_createdWith': u'urn:domeo:software:id:Domeo-2.0alpha-040',
                          u'pav_!DOMEO_NS!_lastSavedOn': '2015-09-29 09:04:36 -0400',
                          u'pav_!DOMEO_NS!_lineageUri': 'urn:domeoserver:annotation:eb20fe17-27e4-4aee-a209-8f897d5ce306',
                          u'pav_!DOMEO_NS!_previousVersion': u'',
                          u'pav_!DOMEO_NS!_versionNumber': 1,
                          u'rdfs_!DOMEO_NS!_label': u'ddi Annotation'}],
 u'dct_!DOMEO_NS!_description': u'The default set is created automatically by Domeo when no other set is existing.',
 u'domeo_!DOMEO_NS!_agents': [{u'@id': 'urn:person:uuid:ff808181508ae86901508ae930ec0000',
                               u'@type': u'foafx:Person',
                               u'foafx_!DOMEO_NS!_email': u'admin@commonsemantics.org',
                               u'foafx_!DOMEO_NS!_firstname': u'Richard',
                               u'foafx_!DOMEO_NS!_homepage': u'',
                               u'foafx_!DOMEO_NS!_lastname': u'Boyce',
                               u'foafx_!DOMEO_NS!_middlename': u'',
                               u'foafx_!DOMEO_NS!_name': u'Dr. Boyce',
                               u'foafx_!DOMEO_NS!_picture': u'http://www.hcklab.org/images/me/paolo%20ciccarese-boston.jpg',
                               u'foafx_!DOMEO_NS!_title': u'',
                               u'rdfs_!DOMEO_NS!_label': u'Dr. Boyce'},
                              {u'@id': u'urn:domeo:software:id:Domeo-2.0alpha-040',
                               u'@type': u'foafx:Software',
                               u'foafx_!DOMEO_NS!_build': u'040',
                               u'foafx_!DOMEO_NS!_homepage': u'',
                               u'foafx_!DOMEO_NS!_name': u'Domeo Annotation Toolkit',
                               u'foafx_!DOMEO_NS!_version': u'2.0alpha',
                               u'rdfs_!DOMEO_NS!_label': u'Domeo Annotation Toolkit'}],
 u'domeo_!DOMEO_NS!_deleted': u'false',
 u'domeo_!DOMEO_NS!_resources': [{u'label': u'DailyMed - PAROXETINE - paroxetine hydrochloride hemihydrate tablet, film coated',
                                  u'url': 'http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/ea35caf8-c8c8-481a-97a2-25f68cbc240b.html'}],
 u'pav_!DOMEO_NS!_createdBy': 'urn:person:uuid:ff808181508ae86901508ae930ec0000',
 u'pav_!DOMEO_NS!_createdOn': '2015-09-29 09:04:36 -0400',
 u'pav_!DOMEO_NS!_createdWith': u'urn:domeo:software:id:Domeo-2.0alpha-040',
 u'pav_!DOMEO_NS!_lastSavedOn': '2015-09-29 09:04:36 -0400',
 u'pav_!DOMEO_NS!_lineageUri': 'urn:domeoserver:annotationset:0a6efa7b-34a2-449d-af86-4592a73972a5',
 u'pav_!DOMEO_NS!_previousVersion': u'urn:domeoclient:uuid:F5307257-D84B-4C3E-973B-289ABAAE53DE',
 u'pav_!DOMEO_NS!_versionNumber': 1,
 u'permissions_!DOMEO_NS!_permissions': {u'permissions_!DOMEO_NS!_accessType': u'urn:domeo:access:public',
                                         u'permissions_!DOMEO_NS!_isLocked': u'false'},
 u'rdfs_!DOMEO_NS!_label': u'Default Set'}
load annotations for http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/ea35caf8-c8c8-481a-97a2-25f68cbc240b.html
{'objectFormulation': '', 'drug1rxc': 'http://purl.bioontology.org/ontology/RXNORM/3247', 'suffix': '', 'cl': '', 'drug2Role': 'dikbD2R:precipitant-drug-of-interaction', 'cmaxType': '', 'prefix': 'DOSAGE AND ADMINISTRATION ).  Drug-Drug Interactions\xc2\xa0   ', 'modality': 'ncit:positive', 'drug2rxc': 'http://purl.bioontology.org/ontology/RXNORM/32937', 'drug2Lab': 'paroxetine', 'auc': '', 'clDirection': '', 'drug1Lab': 'desipramine', 'source': 'http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/326e8ab0-6886-4749-9544-885b37070051.html', 't12': '', 'aucDirection': '', 't12Direction': '', 'clType': '', 't12Type': '', 'drug1Type': 'dikbD2R:active-ingredient', 'numOfParticipants': '', 'statementType': 'ncit:Qualitative', 'objectRegimens': '', 'drug2Type': 'dikbD2R:active-ingredient', 'aucType': '', 'exactText': 'In vitro drug interaction studies reveal that paroxetine inhibits CYP2D6. Clinical drug interaction studies have been performed with substrates of CYP2D6 and show that paroxetine can inhibit the metabolism of drugs metabolized by CYP2D6 including desipramine, risperidone, and atomoxetine (see PRECAUTIONS: Drug Interactions).', 'dose1': '', 'dose2': '', 'date': '2015-09-14 10:25:07 -0400', 'cmaxDirection': '', 'assertionType': 'drug-drug-interaction', 'drug1Role': 'dikbD2R:object-drug-of-interaction', 'preciptFormulation': '', 'preciptDuration': '', 'objectDuration': '', 'evidenceType': 'evidence-supports', 'preciptRegimens': '', 'cmax': ''}
{u'@id': 'urn:domeoclient:uuid:b56f944d-63dd-4c47-9d2e-7b021dbae40b',
 u'@type': u'ao:AnnotationSet',
 u'ao_!DOMEO_NS!_annotatesResource': 'http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/326e8ab0-6886-4749-9544-885b37070051.html',
 u'ao_!DOMEO_NS!_item': [{u'@id': 'urn:domeoclient:uuid:2d4ed1f8-9551-4fa5-8898-e50e897ed70a',
                          u'@type': u'ao:ddiAnnotation',
                          u'ao_!DOMEO_NS!_body': [{u'sets': {u'@id': 'urn:pddi:uuid:2baefaab-bfe5-4dc9-a17b-07900b878027',
                                                             u'@type': u'poc:DrugDrugInteractionStatement',
                                                             u'dikbD2R_!DOMEO_NS!_modality': 'ncit:positive',
                                                             u'dikbD2R_!DOMEO_NS!_statement': 'ncit:Qualitative',
                                                             u'sio_!DOMEO_NS!_SIO_000205': u'dikbD2R:statement',
                                                             u'sio_!DOMEO_NS!_SIO_000563': u'dikbD2R:modality',
                                                             u'sio_!DOMEO_NS!_SIO_000628': [{u'@id': 'urn:pddi:uuid:7d4ffccd-5947-4c89-8c9a-af0158c280d3',
                                                                                             u'@type': u'dikbD2R:PK_DDI',
                                                                                             u'dikbD2R_!DOMEO_NS!_auc': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_aucDirection': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_aucType': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_cl': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_clDirection': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_clType': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_cmax': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_cmaxDirection': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_cmaxType': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_numOfParticipants': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_objectDuration': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_objectFormulation': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_objectRegimens': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_preciptDuration': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_preciptFormulation': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_preciptRegimens': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_t12': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_t12Direction': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_t12Type': '',
                                                                                             u'sio_!DOMEO_NS!_SIO_000132': [{u'@id': '20eaa5d6-8802-4930-bd9f-f5104e0c8ab0',
                                                                                                                             u'@type': 'dikbD2R:active-ingredient',
                                                                                                                             u'dailymed_!DOMEO_NS!_activeMoietyRxCUI': 'http://purl.bioontology.org/ontology/RXNORM/3247',
                                                                                                                             u'dct_!DOMEO_NS!_description': u'Referred to the drug in the interaction.',
                                                                                                                             u'dikbD2R_!DOMEO_NS!_dose': '',
                                                                                                                             u'rdfs_!DOMEO_NS!_label': 'desipramine',
                                                                                                                             u'sio_!DOMEO_NS!_SIO_000228': 'dikbD2R:object-drug-of-interaction'},
                                                                                                                            {u'@id': '03b76ba9-15d6-4a0f-a0b3-ab44950b8631',
                                                                                                                             u'@type': 'dikbD2R:active-ingredient',
                                                                                                                             u'dailymed_!DOMEO_NS!_activeMoietyRxCUI': 'http://purl.bioontology.org/ontology/RXNORM/32937',
                                                                                                                             u'dct_!DOMEO_NS!_description': u'Referred to the drug in the interaction.',
                                                                                                                             u'dikbD2R_!DOMEO_NS!_dose': '',
                                                                                                                             u'rdfs_!DOMEO_NS!_label': 'paroxetine',
                                                                                                                             u'sio_!DOMEO_NS!_SIO_000228': 'dikbD2R:precipitant-drug-of-interaction'}]}]}}],
                          u'ao_!DOMEO_NS!_context': [{u'@id': 'urn:domeoclient:uuid:e7827ae0-c894-4db5-9fd2-a3bcfb74fc60',
                                                      u'@type': u'ao:SpecificResource',
                                                      u'ao_!DOMEO_NS!_hasSelector': {u'@id': 'urn:domeoclient:uuid:6a6e2bc1-ec53-48af-874a-93f74909da15',
                                                                                     u'@type': u'ao:PrefixSuffixTextSelector',
                                                                                     u'ao_!DOMEO_NS!_exact': 'In vitro drug interaction studies reveal that paroxetine inhibits CYP2D6. Clinical drug interaction studies have been performed with substrates of CYP2D6 and show that paroxetine can inhibit the metabolism of drugs metabolized by CYP2D6 including desipramine, risperidone, and atomoxetine (see PRECAUTIONS: Drug Interactions).',
                                                                                     u'ao_!DOMEO_NS!_prefix': ').  Drug-Drug Interactions\xc2\xa0   ',
                                                                                     u'ao_!DOMEO_NS!_suffix': '',
                                                                                     u'domeo_!DOMEO_NS!_uuid': '5bf65308-fd3e-4c02-829f-cd631811f82d',
                                                                                     u'domeo_temp_localId': u'1',
                                                                                     u'pav_!DOMEO_NS!_createdOn': '2015-09-14 10:25:07 -0400'},
                                                      u'ao_!DOMEO_NS!_hasSource': 'http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/326e8ab0-6886-4749-9544-885b37070051.html',
                                                      u'domeo_temp_localId': u'1'}],
                          u'dikbD2R_!DOMEO_NS!_assertionType': 'drug-drug-interaction',
                          u'dikbD2R_!DOMEO_NS!_evidenceType': u'evidence-challenges',
                          u'domeo_!DOMEO_NS!_belongsToSet': 'urn:domeoclient:uuid:b56f944d-63dd-4c47-9d2e-7b021dbae40b',
                          u'pav_!DOMEO_NS!_createdBy': 'urn:person:uuid:ff808181508ae86901508ae930ec0000',
                          u'pav_!DOMEO_NS!_createdOn': '2015-09-14 10:25:07 -0400',
                          u'pav_!DOMEO_NS!_createdWith': u'urn:domeo:software:id:Domeo-2.0alpha-040',
                          u'pav_!DOMEO_NS!_lastSavedOn': '2015-09-14 10:25:07 -0400',
                          u'pav_!DOMEO_NS!_lineageUri': 'urn:domeoserver:annotation:d5b946c5-892e-4db4-8e37-20ccd30aa359',
                          u'pav_!DOMEO_NS!_previousVersion': u'',
                          u'pav_!DOMEO_NS!_versionNumber': 1,
                          u'rdfs_!DOMEO_NS!_label': u'ddi Annotation'}],
 u'dct_!DOMEO_NS!_description': u'The default set is created automatically by Domeo when no other set is existing.',
 u'domeo_!DOMEO_NS!_agents': [{u'@id': 'urn:person:uuid:ff808181508ae86901508ae930ec0000',
                               u'@type': u'foafx:Person',
                               u'foafx_!DOMEO_NS!_email': u'admin@commonsemantics.org',
                               u'foafx_!DOMEO_NS!_firstname': u'Richard',
                               u'foafx_!DOMEO_NS!_homepage': u'',
                               u'foafx_!DOMEO_NS!_lastname': u'Boyce',
                               u'foafx_!DOMEO_NS!_middlename': u'',
                               u'foafx_!DOMEO_NS!_name': u'Dr. Boyce',
                               u'foafx_!DOMEO_NS!_picture': u'http://www.hcklab.org/images/me/paolo%20ciccarese-boston.jpg',
                               u'foafx_!DOMEO_NS!_title': u'',
                               u'rdfs_!DOMEO_NS!_label': u'Dr. Boyce'},
                              {u'@id': u'urn:domeo:software:id:Domeo-2.0alpha-040',
                               u'@type': u'foafx:Software',
                               u'foafx_!DOMEO_NS!_build': u'040',
                               u'foafx_!DOMEO_NS!_homepage': u'',
                               u'foafx_!DOMEO_NS!_name': u'Domeo Annotation Toolkit',
                               u'foafx_!DOMEO_NS!_version': u'2.0alpha',
                               u'rdfs_!DOMEO_NS!_label': u'Domeo Annotation Toolkit'}],
 u'domeo_!DOMEO_NS!_deleted': u'false',
 u'domeo_!DOMEO_NS!_resources': [{u'label': u'DailyMed - PAROXETINE - paroxetine hydrochloride hemihydrate tablet, film coated',
                                  u'url': 'http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/326e8ab0-6886-4749-9544-885b37070051.html'}],
 u'pav_!DOMEO_NS!_createdBy': 'urn:person:uuid:ff808181508ae86901508ae930ec0000',
 u'pav_!DOMEO_NS!_createdOn': '2015-09-14 10:25:07 -0400',
 u'pav_!DOMEO_NS!_createdWith': u'urn:domeo:software:id:Domeo-2.0alpha-040',
 u'pav_!DOMEO_NS!_lastSavedOn': '2015-09-14 10:25:07 -0400',
 u'pav_!DOMEO_NS!_lineageUri': 'urn:domeoserver:annotationset:cff99dc3-a3ee-4fc2-bc51-4533b9d38bd0',
 u'pav_!DOMEO_NS!_previousVersion': u'urn:domeoclient:uuid:F5307257-D84B-4C3E-973B-289ABAAE53DE',
 u'pav_!DOMEO_NS!_versionNumber': 1,
 u'permissions_!DOMEO_NS!_permissions': {u'permissions_!DOMEO_NS!_accessType': u'urn:domeo:access:public',
                                         u'permissions_!DOMEO_NS!_isLocked': u'false'},
 u'rdfs_!DOMEO_NS!_label': u'Default Set'}
load annotations for http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/326e8ab0-6886-4749-9544-885b37070051.html
{'objectFormulation': '', 'drug1rxc': 'http://purl.bioontology.org/ontology/RXNORM/', 'suffix': '', 'cl': '', 'drug2Role': 'dikbD2R:precipitant-drug-of-interaction', 'cmaxType': '', 'prefix': 'on BCRP and organic anion transporting polypeptide B1 and B3 (OATP1B1/1B3) substrates   ', 'modality': 'ncit:positive', 'drug2rxc': 'http://purl.bioontology.org/ontology/RXNORM/', 'drug2Lab': 'Teriflunomide', 'auc': '', 'clDirection': '', 'drug1Lab': 'nateglinide', 'source': 'http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/4650d12c-b9c8-4525-b07f-a2d773eca155.html', 't12': '', 'aucDirection': '', 't12Direction': '', 'clType': '', 't12Type': '', 'drug1Type': 'dikbD2R:active-ingredient', 'numOfParticipants': '', 'statementType': 'ncit:Qualitative', 'objectRegimens': '', 'drug2Type': 'dikbD2R:active-ingredient', 'aucType': '', 'exactText': 'Teriflunomide inhibits the activity of BCRP and OATP1B1/1B3 in vivo. For a patient taking AUBAGIO, the dose of rosuvastatin should not exceed 10 mg once daily. For other substrates of BCRP (e.g., mitoxantrone) and drugs in the OATP family (e.g., methotrexate, rifampin), especially HMG-Co reductase inhibitors (e.g., atorvastatin, nateglinide, pravastatin, repaglinide, and simvastatin), consider reducing the dose of these drugs and monitor patients closely for signs and symptoms of increased exposures to the drugs while patients are taking AUBAGIO [see Clinical Pharmacology (12.3)].', 'dose1': '', 'dose2': '', 'date': '2015-08-20 12:50:04 -0400', 'cmaxDirection': '', 'assertionType': 'drug-drug-interaction', 'drug1Role': 'dikbD2R:object-drug-of-interaction', 'preciptFormulation': '', 'preciptDuration': '', 'objectDuration': '', 'evidenceType': 'evidence-supports', 'preciptRegimens': '', 'cmax': ''}
{u'@id': 'urn:domeoclient:uuid:63d610d4-8a05-44d2-8614-b689d4ed3556',
 u'@type': u'ao:AnnotationSet',
 u'ao_!DOMEO_NS!_annotatesResource': 'http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/4650d12c-b9c8-4525-b07f-a2d773eca155.html',
 u'ao_!DOMEO_NS!_item': [{u'@id': 'urn:domeoclient:uuid:19c17736-2885-4f7a-b865-df66f3fef35e',
                          u'@type': u'ao:ddiAnnotation',
                          u'ao_!DOMEO_NS!_body': [{u'sets': {u'@id': 'urn:pddi:uuid:532177a8-cf39-45eb-b036-0a11ba43ab7a',
                                                             u'@type': u'poc:DrugDrugInteractionStatement',
                                                             u'dikbD2R_!DOMEO_NS!_modality': 'ncit:positive',
                                                             u'dikbD2R_!DOMEO_NS!_statement': 'ncit:Qualitative',
                                                             u'sio_!DOMEO_NS!_SIO_000205': u'dikbD2R:statement',
                                                             u'sio_!DOMEO_NS!_SIO_000563': u'dikbD2R:modality',
                                                             u'sio_!DOMEO_NS!_SIO_000628': [{u'@id': 'urn:pddi:uuid:c055db68-d08c-4659-99c7-9d5a7b87ec68',
                                                                                             u'@type': u'dikbD2R:PK_DDI',
                                                                                             u'dikbD2R_!DOMEO_NS!_auc': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_aucDirection': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_aucType': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_cl': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_clDirection': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_clType': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_cmax': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_cmaxDirection': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_cmaxType': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_numOfParticipants': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_objectDuration': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_objectFormulation': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_objectRegimens': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_preciptDuration': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_preciptFormulation': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_preciptRegimens': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_t12': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_t12Direction': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_t12Type': '',
                                                                                             u'sio_!DOMEO_NS!_SIO_000132': [{u'@id': '81678f60-da61-49f2-9d41-7c8c47a822fa',
                                                                                                                             u'@type': 'dikbD2R:active-ingredient',
                                                                                                                             u'dailymed_!DOMEO_NS!_activeMoietyRxCUI': 'http://purl.bioontology.org/ontology/RXNORM/',
                                                                                                                             u'dct_!DOMEO_NS!_description': u'Referred to the drug in the interaction.',
                                                                                                                             u'dikbD2R_!DOMEO_NS!_dose': '',
                                                                                                                             u'rdfs_!DOMEO_NS!_label': 'nateglinide',
                                                                                                                             u'sio_!DOMEO_NS!_SIO_000228': 'dikbD2R:object-drug-of-interaction'},
                                                                                                                            {u'@id': 'b975e81a-4f26-4c2c-b973-49a792954762',
                                                                                                                             u'@type': 'dikbD2R:active-ingredient',
                                                                                                                             u'dailymed_!DOMEO_NS!_activeMoietyRxCUI': 'http://purl.bioontology.org/ontology/RXNORM/',
                                                                                                                             u'dct_!DOMEO_NS!_description': u'Referred to the drug in the interaction.',
                                                                                                                             u'dikbD2R_!DOMEO_NS!_dose': '',
                                                                                                                             u'rdfs_!DOMEO_NS!_label': 'Teriflunomide',
                                                                                                                             u'sio_!DOMEO_NS!_SIO_000228': 'dikbD2R:precipitant-drug-of-interaction'}]}]}}],
                          u'ao_!DOMEO_NS!_context': [{u'@id': 'urn:domeoclient:uuid:a10c7a58-74b9-4ec8-936a-aa8c6f955eff',
                                                      u'@type': u'ao:SpecificResource',
                                                      u'ao_!DOMEO_NS!_hasSelector': {u'@id': 'urn:domeoclient:uuid:a2c8c88e-06ac-427d-bedb-0873befd3f0a',
                                                                                     u'@type': u'ao:PrefixSuffixTextSelector',
                                                                                     u'ao_!DOMEO_NS!_exact': 'Teriflunomide inhibits the activity of BCRP and OATP1B1/1B3 in vivo. For a patient taking AUBAGIO, the dose of rosuvastatin should not exceed 10 mg once daily. For other substrates of BCRP (e.g., mitoxantrone) and drugs in the OATP family (e.g., methotrexate, rifampin), especially HMG-Co reductase inhibitors (e.g., atorvastatin, nateglinide, pravastatin, repaglinide, and simvastatin), consider reducing the dose of these drugs and monitor patients closely for signs and symptoms of increased exposures to the drugs while patients are taking AUBAGIO [see Clinical Pharmacology (12.3)].',
                                                                                     u'ao_!DOMEO_NS!_prefix': ' B3 (OATP1B1/1B3) substrates   ',
                                                                                     u'ao_!DOMEO_NS!_suffix': '',
                                                                                     u'domeo_!DOMEO_NS!_uuid': 'a0a5a1c3-5fd5-4cfd-a5a4-005ca85e999e',
                                                                                     u'domeo_temp_localId': u'1',
                                                                                     u'pav_!DOMEO_NS!_createdOn': '2015-08-20 12:50:04 -0400'},
                                                      u'ao_!DOMEO_NS!_hasSource': 'http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/4650d12c-b9c8-4525-b07f-a2d773eca155.html',
                                                      u'domeo_temp_localId': u'1'}],
                          u'dikbD2R_!DOMEO_NS!_assertionType': 'drug-drug-interaction',
                          u'dikbD2R_!DOMEO_NS!_evidenceType': u'evidence-challenges',
                          u'domeo_!DOMEO_NS!_belongsToSet': 'urn:domeoclient:uuid:63d610d4-8a05-44d2-8614-b689d4ed3556',
                          u'pav_!DOMEO_NS!_createdBy': 'urn:person:uuid:ff808181508ae86901508ae930ec0000',
                          u'pav_!DOMEO_NS!_createdOn': '2015-08-20 12:50:04 -0400',
                          u'pav_!DOMEO_NS!_createdWith': u'urn:domeo:software:id:Domeo-2.0alpha-040',
                          u'pav_!DOMEO_NS!_lastSavedOn': '2015-08-20 12:50:04 -0400',
                          u'pav_!DOMEO_NS!_lineageUri': 'urn:domeoserver:annotation:0008b82a-fff6-4b09-8916-0abc56a831b8',
                          u'pav_!DOMEO_NS!_previousVersion': u'',
                          u'pav_!DOMEO_NS!_versionNumber': 1,
                          u'rdfs_!DOMEO_NS!_label': u'ddi Annotation'}],
 u'dct_!DOMEO_NS!_description': u'The default set is created automatically by Domeo when no other set is existing.',
 u'domeo_!DOMEO_NS!_agents': [{u'@id': 'urn:person:uuid:ff808181508ae86901508ae930ec0000',
                               u'@type': u'foafx:Person',
                               u'foafx_!DOMEO_NS!_email': u'admin@commonsemantics.org',
                               u'foafx_!DOMEO_NS!_firstname': u'Richard',
                               u'foafx_!DOMEO_NS!_homepage': u'',
                               u'foafx_!DOMEO_NS!_lastname': u'Boyce',
                               u'foafx_!DOMEO_NS!_middlename': u'',
                               u'foafx_!DOMEO_NS!_name': u'Dr. Boyce',
                               u'foafx_!DOMEO_NS!_picture': u'http://www.hcklab.org/images/me/paolo%20ciccarese-boston.jpg',
                               u'foafx_!DOMEO_NS!_title': u'',
                               u'rdfs_!DOMEO_NS!_label': u'Dr. Boyce'},
                              {u'@id': u'urn:domeo:software:id:Domeo-2.0alpha-040',
                               u'@type': u'foafx:Software',
                               u'foafx_!DOMEO_NS!_build': u'040',
                               u'foafx_!DOMEO_NS!_homepage': u'',
                               u'foafx_!DOMEO_NS!_name': u'Domeo Annotation Toolkit',
                               u'foafx_!DOMEO_NS!_version': u'2.0alpha',
                               u'rdfs_!DOMEO_NS!_label': u'Domeo Annotation Toolkit'}],
 u'domeo_!DOMEO_NS!_deleted': u'false',
 u'domeo_!DOMEO_NS!_resources': [{u'label': u'DailyMed - PAROXETINE - paroxetine hydrochloride hemihydrate tablet, film coated',
                                  u'url': 'http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/4650d12c-b9c8-4525-b07f-a2d773eca155.html'}],
 u'pav_!DOMEO_NS!_createdBy': 'urn:person:uuid:ff808181508ae86901508ae930ec0000',
 u'pav_!DOMEO_NS!_createdOn': '2015-08-20 12:50:04 -0400',
 u'pav_!DOMEO_NS!_createdWith': u'urn:domeo:software:id:Domeo-2.0alpha-040',
 u'pav_!DOMEO_NS!_lastSavedOn': '2015-08-20 12:50:04 -0400',
 u'pav_!DOMEO_NS!_lineageUri': 'urn:domeoserver:annotationset:8e3d0a47-130d-4a42-b2b7-cf09c6760e08',
 u'pav_!DOMEO_NS!_previousVersion': u'urn:domeoclient:uuid:F5307257-D84B-4C3E-973B-289ABAAE53DE',
 u'pav_!DOMEO_NS!_versionNumber': 1,
 u'permissions_!DOMEO_NS!_permissions': {u'permissions_!DOMEO_NS!_accessType': u'urn:domeo:access:public',
                                         u'permissions_!DOMEO_NS!_isLocked': u'false'},
 u'rdfs_!DOMEO_NS!_label': u'Default Set'}
load annotations for http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/4650d12c-b9c8-4525-b07f-a2d773eca155.html
{'objectFormulation': '', 'drug1rxc': 'http://purl.bioontology.org/ontology/RXNORM/21212', 'suffix': '', 'cl': '', 'drug2Role': 'dikbD2R:object-drug-of-interaction', 'cmaxType': '', 'prefix': 'dosage should be considered. (See Viagra package insert .)  ', 'modality': 'ncit:positive', 'drug2rxc': 'http://purl.bioontology.org/ontology/RXNORM/2002', 'drug2Lab': 'carbamazepine', 'auc': '', 'clDirection': '', 'drug1Lab': 'clarithromycin', 'source': 'http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/38642D80-AAA6-4196-A033-3977FF35B48A.html', 't12': '', 'aucDirection': '', 't12Direction': '', 'clType': '', 't12Type': '', 'drug1Type': 'dikbD2R:active-ingredient', 'numOfParticipants': '', 'statementType': 'ncit:Qualitative', 'objectRegimens': '', 'drug2Type': 'dikbD2R:active-ingredient', 'aucType': '', 'exactText': 'There have been spontaneous or published reports of CYP3A based interactions of erythromycin and/or clarithromycin with cyclosporine, carbamazepine, tacrolimus, alfentanil, disopyramide, rifabutin, quinidine, methylprednisolone, cilostazol, and bromocriptine.', 'dose1': '', 'dose2': '', 'date': '2015-10-13 12:04:13 -0400', 'cmaxDirection': '', 'assertionType': 'drug-drug-interaction', 'drug1Role': 'dikbD2R:precipitant-drug-of-interaction', 'preciptFormulation': '', 'preciptDuration': '', 'objectDuration': '', 'evidenceType': 'evidence-supports', 'preciptRegimens': '', 'cmax': ''}
{u'@id': 'urn:domeoclient:uuid:5ba25769-bb6c-4b86-9af0-5bbb595c7eb0',
 u'@type': u'ao:AnnotationSet',
 u'ao_!DOMEO_NS!_annotatesResource': 'http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/38642D80-AAA6-4196-A033-3977FF35B48A.html',
 u'ao_!DOMEO_NS!_item': [{u'@id': 'urn:domeoclient:uuid:751fb90c-4f43-4793-bb5e-593416e59f9d',
                          u'@type': u'ao:ddiAnnotation',
                          u'ao_!DOMEO_NS!_body': [{u'sets': {u'@id': 'urn:pddi:uuid:31bf8c38-8e76-4590-8eb1-74c98a5a1dcb',
                                                             u'@type': u'poc:DrugDrugInteractionStatement',
                                                             u'dikbD2R_!DOMEO_NS!_modality': 'ncit:positive',
                                                             u'dikbD2R_!DOMEO_NS!_statement': 'ncit:Qualitative',
                                                             u'sio_!DOMEO_NS!_SIO_000205': u'dikbD2R:statement',
                                                             u'sio_!DOMEO_NS!_SIO_000563': u'dikbD2R:modality',
                                                             u'sio_!DOMEO_NS!_SIO_000628': [{u'@id': 'urn:pddi:uuid:193d818e-a843-4af5-8a85-ef11d56b8af1',
                                                                                             u'@type': u'dikbD2R:PK_DDI',
                                                                                             u'dikbD2R_!DOMEO_NS!_auc': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_aucDirection': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_aucType': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_cl': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_clDirection': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_clType': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_cmax': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_cmaxDirection': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_cmaxType': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_numOfParticipants': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_objectDuration': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_objectFormulation': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_objectRegimens': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_preciptDuration': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_preciptFormulation': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_preciptRegimens': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_t12': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_t12Direction': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_t12Type': '',
                                                                                             u'sio_!DOMEO_NS!_SIO_000132': [{u'@id': '079d0e15-c632-4305-a341-618c931aced6',
                                                                                                                             u'@type': 'dikbD2R:active-ingredient',
                                                                                                                             u'dailymed_!DOMEO_NS!_activeMoietyRxCUI': 'http://purl.bioontology.org/ontology/RXNORM/21212',
                                                                                                                             u'dct_!DOMEO_NS!_description': u'Referred to the drug in the interaction.',
                                                                                                                             u'dikbD2R_!DOMEO_NS!_dose': '',
                                                                                                                             u'rdfs_!DOMEO_NS!_label': 'clarithromycin',
                                                                                                                             u'sio_!DOMEO_NS!_SIO_000228': 'dikbD2R:precipitant-drug-of-interaction'},
                                                                                                                            {u'@id': '4234addc-9288-4e02-bbf4-5e0081a7a21d',
                                                                                                                             u'@type': 'dikbD2R:active-ingredient',
                                                                                                                             u'dailymed_!DOMEO_NS!_activeMoietyRxCUI': 'http://purl.bioontology.org/ontology/RXNORM/2002',
                                                                                                                             u'dct_!DOMEO_NS!_description': u'Referred to the drug in the interaction.',
                                                                                                                             u'dikbD2R_!DOMEO_NS!_dose': '',
                                                                                                                             u'rdfs_!DOMEO_NS!_label': 'carbamazepine',
                                                                                                                             u'sio_!DOMEO_NS!_SIO_000228': 'dikbD2R:object-drug-of-interaction'}]}]}}],
                          u'ao_!DOMEO_NS!_context': [{u'@id': 'urn:domeoclient:uuid:278b2484-4583-4b38-bf51-8f63d719a007',
                                                      u'@type': u'ao:SpecificResource',
                                                      u'ao_!DOMEO_NS!_hasSelector': {u'@id': 'urn:domeoclient:uuid:17478c5f-7607-40b0-8156-1b2851693626',
                                                                                     u'@type': u'ao:PrefixSuffixTextSelector',
                                                                                     u'ao_!DOMEO_NS!_exact': 'There have been spontaneous or published reports of CYP3A based interactions of erythromycin and/or clarithromycin with cyclosporine, carbamazepine, tacrolimus, alfentanil, disopyramide, rifabutin, quinidine, methylprednisolone, cilostazol, and bromocriptine.',
                                                                                     u'ao_!DOMEO_NS!_prefix': '(See Viagra package insert .)  ',
                                                                                     u'ao_!DOMEO_NS!_suffix': '',
                                                                                     u'domeo_!DOMEO_NS!_uuid': '535ec4d0-8406-4e6d-a52f-61249bfa170b',
                                                                                     u'domeo_temp_localId': u'1',
                                                                                     u'pav_!DOMEO_NS!_createdOn': '2015-10-13 12:04:13 -0400'},
                                                      u'ao_!DOMEO_NS!_hasSource': 'http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/38642D80-AAA6-4196-A033-3977FF35B48A.html',
                                                      u'domeo_temp_localId': u'1'}],
                          u'dikbD2R_!DOMEO_NS!_assertionType': 'drug-drug-interaction',
                          u'dikbD2R_!DOMEO_NS!_evidenceType': u'evidence-challenges',
                          u'domeo_!DOMEO_NS!_belongsToSet': 'urn:domeoclient:uuid:5ba25769-bb6c-4b86-9af0-5bbb595c7eb0',
                          u'pav_!DOMEO_NS!_createdBy': 'urn:person:uuid:ff808181508ae86901508ae930ec0000',
                          u'pav_!DOMEO_NS!_createdOn': '2015-10-13 12:04:13 -0400',
                          u'pav_!DOMEO_NS!_createdWith': u'urn:domeo:software:id:Domeo-2.0alpha-040',
                          u'pav_!DOMEO_NS!_lastSavedOn': '2015-10-13 12:04:13 -0400',
                          u'pav_!DOMEO_NS!_lineageUri': 'urn:domeoserver:annotation:e465a3b6-18b2-42b9-a787-7f711d724f40',
                          u'pav_!DOMEO_NS!_previousVersion': u'',
                          u'pav_!DOMEO_NS!_versionNumber': 1,
                          u'rdfs_!DOMEO_NS!_label': u'ddi Annotation'}],
 u'dct_!DOMEO_NS!_description': u'The default set is created automatically by Domeo when no other set is existing.',
 u'domeo_!DOMEO_NS!_agents': [{u'@id': 'urn:person:uuid:ff808181508ae86901508ae930ec0000',
                               u'@type': u'foafx:Person',
                               u'foafx_!DOMEO_NS!_email': u'admin@commonsemantics.org',
                               u'foafx_!DOMEO_NS!_firstname': u'Richard',
                               u'foafx_!DOMEO_NS!_homepage': u'',
                               u'foafx_!DOMEO_NS!_lastname': u'Boyce',
                               u'foafx_!DOMEO_NS!_middlename': u'',
                               u'foafx_!DOMEO_NS!_name': u'Dr. Boyce',
                               u'foafx_!DOMEO_NS!_picture': u'http://www.hcklab.org/images/me/paolo%20ciccarese-boston.jpg',
                               u'foafx_!DOMEO_NS!_title': u'',
                               u'rdfs_!DOMEO_NS!_label': u'Dr. Boyce'},
                              {u'@id': u'urn:domeo:software:id:Domeo-2.0alpha-040',
                               u'@type': u'foafx:Software',
                               u'foafx_!DOMEO_NS!_build': u'040',
                               u'foafx_!DOMEO_NS!_homepage': u'',
                               u'foafx_!DOMEO_NS!_name': u'Domeo Annotation Toolkit',
                               u'foafx_!DOMEO_NS!_version': u'2.0alpha',
                               u'rdfs_!DOMEO_NS!_label': u'Domeo Annotation Toolkit'}],
 u'domeo_!DOMEO_NS!_deleted': u'false',
 u'domeo_!DOMEO_NS!_resources': [{u'label': u'DailyMed - PAROXETINE - paroxetine hydrochloride hemihydrate tablet, film coated',
                                  u'url': 'http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/38642D80-AAA6-4196-A033-3977FF35B48A.html'}],
 u'pav_!DOMEO_NS!_createdBy': 'urn:person:uuid:ff808181508ae86901508ae930ec0000',
 u'pav_!DOMEO_NS!_createdOn': '2015-10-13 12:04:13 -0400',
 u'pav_!DOMEO_NS!_createdWith': u'urn:domeo:software:id:Domeo-2.0alpha-040',
 u'pav_!DOMEO_NS!_lastSavedOn': '2015-10-13 12:04:13 -0400',
 u'pav_!DOMEO_NS!_lineageUri': 'urn:domeoserver:annotationset:36241f17-de6c-4be0-add8-7c3c8fe54004',
 u'pav_!DOMEO_NS!_previousVersion': u'urn:domeoclient:uuid:F5307257-D84B-4C3E-973B-289ABAAE53DE',
 u'pav_!DOMEO_NS!_versionNumber': 1,
 u'permissions_!DOMEO_NS!_permissions': {u'permissions_!DOMEO_NS!_accessType': u'urn:domeo:access:public',
                                         u'permissions_!DOMEO_NS!_isLocked': u'false'},
 u'rdfs_!DOMEO_NS!_label': u'Default Set'}
load annotations for http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/38642D80-AAA6-4196-A033-3977FF35B48A.html
{'objectFormulation': '', 'drug1rxc': 'http://purl.bioontology.org/ontology/RXNORM/', 'suffix': '', 'cl': '', 'drug2Role': 'dikbD2R:object-drug-of-interaction', 'cmaxType': '', 'prefix': 'is rapidly tapered in patients receiving maprotiline .  ', 'modality': 'ncit:positive', 'drug2rxc': 'http://purl.bioontology.org/ontology/RXNORM/', 'drug2Lab': 'maprotiline', 'auc': '', 'clDirection': '', 'drug1Lab': 'barbiturates', 'source': 'http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/c3ca69e6-1ea0-4c2c-abcb-7264b2e79a87.html', 't12': '', 'aucDirection': '', 't12Direction': '', 'clType': '', 't12Type': '', 'drug1Type': 'dikbD2R:drug-group', 'numOfParticipants': '', 'statementType': 'ncit:Qualitative', 'objectRegimens': '', 'drug2Type': 'dikbD2R:active-ingredient', 'aucType': '', 'exactText': 'Because of the pharmacologic similarity of maprotiline hydrochloride to the tricyclic antidepressants, the plasma concentration of maprotiline may be increased when the drug is given concomitantly with hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by concomitant administration with hepatic enzyme inducers (e.g., barbiturates, phenytoin), as has occurred with tricyclic antidepressants. Adjustment of the dosage of maprotiline hydrochloride may therefore be necessary in such cases.', 'dose1': '', 'dose2': '', 'date': '2015-09-30 12:41:52 -0400', 'cmaxDirection': '', 'assertionType': 'drug-drug-interaction', 'drug1Role': 'dikbD2R:precipitant-drug-of-interaction', 'preciptFormulation': '', 'preciptDuration': '', 'objectDuration': '', 'evidenceType': 'evidence-supports', 'preciptRegimens': '', 'cmax': ''}
{u'@id': 'urn:domeoclient:uuid:5aafbb06-8733-4355-a37a-8dd9ed4f46af',
 u'@type': u'ao:AnnotationSet',
 u'ao_!DOMEO_NS!_annotatesResource': 'http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/c3ca69e6-1ea0-4c2c-abcb-7264b2e79a87.html',
 u'ao_!DOMEO_NS!_item': [{u'@id': 'urn:domeoclient:uuid:391943e4-3461-4166-a156-e2eb3bc52b5b',
                          u'@type': u'ao:ddiAnnotation',
                          u'ao_!DOMEO_NS!_body': [{u'sets': {u'@id': 'urn:pddi:uuid:f7c41aef-4076-46df-b686-6001f775ac50',
                                                             u'@type': u'poc:DrugDrugInteractionStatement',
                                                             u'dikbD2R_!DOMEO_NS!_modality': 'ncit:positive',
                                                             u'dikbD2R_!DOMEO_NS!_statement': 'ncit:Qualitative',
                                                             u'sio_!DOMEO_NS!_SIO_000205': u'dikbD2R:statement',
                                                             u'sio_!DOMEO_NS!_SIO_000563': u'dikbD2R:modality',
                                                             u'sio_!DOMEO_NS!_SIO_000628': [{u'@id': 'urn:pddi:uuid:786d3653-c8f0-4926-ada5-3980c504b7cb',
                                                                                             u'@type': u'dikbD2R:PK_DDI',
                                                                                             u'dikbD2R_!DOMEO_NS!_auc': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_aucDirection': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_aucType': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_cl': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_clDirection': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_clType': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_cmax': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_cmaxDirection': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_cmaxType': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_numOfParticipants': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_objectDuration': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_objectFormulation': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_objectRegimens': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_preciptDuration': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_preciptFormulation': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_preciptRegimens': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_t12': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_t12Direction': '',
                                                                                             u'dikbD2R_!DOMEO_NS!_t12Type': '',
                                                                                             u'sio_!DOMEO_NS!_SIO_000132': [{u'@id': '52d915ca-37ab-4710-b6ee-357bdbdf45d0',
                                                                                                                             u'@type': 'dikbD2R:drug-group',
                                                                                                                             u'dailymed_!DOMEO_NS!_activeMoietyRxCUI': 'http://purl.bioontology.org/ontology/RXNORM/',
                                                                                                                             u'dct_!DOMEO_NS!_description': u'Referred to the drug in the interaction.',
                                                                                                                             u'dikbD2R_!DOMEO_NS!_dose': '',
                                                                                                                             u'rdfs_!DOMEO_NS!_label': 'barbiturates',
                                                                                                                             u'sio_!DOMEO_NS!_SIO_000228': 'dikbD2R:precipitant-drug-of-interaction'},
                                                                                                                            {u'@id': '2f3d88e7-f73a-4743-927d-176936cd64e8',
                                                                                                                             u'@type': 'dikbD2R:active-ingredient',
                                                                                                                             u'dailymed_!DOMEO_NS!_activeMoietyRxCUI': 'http://purl.bioontology.org/ontology/RXNORM/',
                                                                                                                             u'dct_!DOMEO_NS!_description': u'Referred to the drug in the interaction.',
                                                                                                                             u'dikbD2R_!DOMEO_NS!_dose': '',
                                                                                                                             u'rdfs_!DOMEO_NS!_label': 'maprotiline',
                                                                                                                             u'sio_!DOMEO_NS!_SIO_000228': 'dikbD2R:object-drug-of-interaction'}]}]}}],
                          u'ao_!DOMEO_NS!_context': [{u'@id': 'urn:domeoclient:uuid:23c7cd94-ec1a-4aeb-83c7-eb0f4c5ad1b9',
                                                      u'@type': u'ao:SpecificResource',
                                                      u'ao_!DOMEO_NS!_hasSelector': {u'@id': 'urn:domeoclient:uuid:1bdd63ae-76f1-442f-b97f-81e5cab392b9',
                                                                                     u'@type': u'ao:PrefixSuffixTextSelector',
                                                                                     u'ao_!DOMEO_NS!_exact': 'Because of the pharmacologic similarity of maprotiline hydrochloride to the tricyclic antidepressants, the plasma concentration of maprotiline may be increased when the drug is given concomitantly with hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by concomitant administration with hepatic enzyme inducers (e.g., barbiturates, phenytoin), as has occurred with tricyclic antidepressants. Adjustment of the dosage of maprotiline hydrochloride may therefore be necessary in such cases.',
                                                                                     u'ao_!DOMEO_NS!_prefix': 'ients receiving maprotiline .  ',
                                                                                     u'ao_!DOMEO_NS!_suffix': '',
                                                                                     u'domeo_!DOMEO_NS!_uuid': 'e3d9a352-8468-4bdc-b94c-d813611385f7',
                                                                                     u'domeo_temp_localId': u'1',
                                                                                     u'pav_!DOMEO_NS!_createdOn': '2015-09-30 12:41:52 -0400'},
                                                      u'ao_!DOMEO_NS!_hasSource': 'http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/c3ca69e6-1ea0-4c2c-abcb-7264b2e79a87.html',
                                                      u'domeo_temp_localId': u'1'}],
                          u'dikbD2R_!DOMEO_NS!_assertionType': 'drug-drug-interaction',
                          u'dikbD2R_!DOMEO_NS!_evidenceType': u'evidence-challenges',
                          u'domeo_!DOMEO_NS!_belongsToSet': 'urn:domeoclient:uuid:5aafbb06-8733-4355-a37a-8dd9ed4f46af',
                          u'pav_!DOMEO_NS!_createdBy': 'urn:person:uuid:ff808181508ae86901508ae930ec0000',
                          u'pav_!DOMEO_NS!_createdOn': '2015-09-30 12:41:52 -0400',
                          u'pav_!DOMEO_NS!_createdWith': u'urn:domeo:software:id:Domeo-2.0alpha-040',
                          u'pav_!DOMEO_NS!_lastSavedOn': '2015-09-30 12:41:52 -0400',
                          u'pav_!DOMEO_NS!_lineageUri': 'urn:domeoserver:annotation:b68cbfb4-3347-413b-9e60-436aaac12e97',
                          u'pav_!DOMEO_NS!_previousVersion': u'',
                          u'pav_!DOMEO_NS!_versionNumber': 1,
                          u'rdfs_!DOMEO_NS!_label': u'ddi Annotation'}],
 u'dct_!DOMEO_NS!_description': u'The default set is created automatically by Domeo when no other set is existing.',
 u'domeo_!DOMEO_NS!_agents': [{u'@id': 'urn:person:uuid:ff808181508ae86901508ae930ec0000',
                               u'@type': u'foafx:Person',
                               u'foafx_!DOMEO_NS!_email': u'admin@commonsemantics.org',
                               u'foafx_!DOMEO_NS!_firstname': u'Richard',
                               u'foafx_!DOMEO_NS!_homepage': u'',
                               u'foafx_!DOMEO_NS!_lastname': u'Boyce',
                               u'foafx_!DOMEO_NS!_middlename': u'',
                               u'foafx_!DOMEO_NS!_name': u'Dr. Boyce',
                               u'foafx_!DOMEO_NS!_picture': u'http://www.hcklab.org/images/me/paolo%20ciccarese-boston.jpg',
                               u'foafx_!DOMEO_NS!_title': u'',
                               u'rdfs_!DOMEO_NS!_label': u'Dr. Boyce'},
                              {u'@id': u'urn:domeo:software:id:Domeo-2.0alpha-040',
                               u'@type': u'foafx:Software',
                               u'foafx_!DOMEO_NS!_build': u'040',
                               u'foafx_!DOMEO_NS!_homepage': u'',
                               u'foafx_!DOMEO_NS!_name': u'Domeo Annotation Toolkit',
                               u'foafx_!DOMEO_NS!_version': u'2.0alpha',
                               u'rdfs_!DOMEO_NS!_label': u'Domeo Annotation Toolkit'}],
 u'domeo_!DOMEO_NS!_deleted': u'false',
 u'domeo_!DOMEO_NS!_resources': [{u'label': u'DailyMed - PAROXETINE - paroxetine hydrochloride hemihydrate tablet, film coated',
                                  u'url': 'http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/c3ca69e6-1ea0-4c2c-abcb-7264b2e79a87.html'}],
 u'pav_!DOMEO_NS!_createdBy': 'urn:person:uuid:ff808181508ae86901508ae930ec0000',
 u'pav_!DOMEO_NS!_createdOn': '2015-09-30 12:41:52 -0400',
 u'pav_!DOMEO_NS!_createdWith': u'urn:domeo:software:id:Domeo-2.0alpha-040',
 u'pav_!DOMEO_NS!_lastSavedOn': '2015-09-30 12:41:52 -0400',
 u'pav_!DOMEO_NS!_lineageUri': 'urn:domeoserver:annotationset:caf42ff6-d7e6-4886-899d-8b0af601e011',
 u'pav_!DOMEO_NS!_previousVersion': u'urn:domeoclient:uuid:F5307257-D84B-4C3E-973B-289ABAAE53DE',
 u'pav_!DOMEO_NS!_versionNumber': 1,
 u'permissions_!DOMEO_NS!_permissions': {u'permissions_!DOMEO_NS!_accessType': u'urn:domeo:access:public',
                                         u'permissions_!DOMEO_NS!_isLocked': u'false'},
 u'rdfs_!DOMEO_NS!_label': u'Default Set'}
load annotations for http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/c3ca69e6-1ea0-4c2c-abcb-7264b2e79a87.html
{'objectFormulation': 'tablet', 'drug1rxc': 'http://purl.bioontology.org/ontology/RXNORM/11289', 'suffix': '', 'cl': 'Unk', 'drug2Role': 'dikbD2R:precipitant-drug-of-interaction', 'cmaxType': 'UNK', 'prefix': 'milnacipran and 150\xc2\xa0mg pregabalin .  ', 'modality': 'ncit:negative', 'drug2rxc': 'http://purl.bioontology.org/ontology/RXNORM/', 'drug2Lab': 'milnacipran', 'auc': 'Unk', 'clDirection': 'UNK', 'drug1Lab': 'warfarin', 'source': 'http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/16a4a314-f97e-4e91-95e9-576a3773d284.html', 't12': 'Unk', 'aucDirection': 'UNK', 't12Direction': 'UNK', 'clType': 'UNK', 't12Type': 'UNK', 'drug1Type': 'dikbD2R:active-ingredient', 'numOfParticipants': 'Unk', 'statementType': 'ncit:quantitative', 'objectRegimens': 'SD', 'drug2Type': 'dikbD2R:active-ingredient', 'aucType': 'UNK', 'exactText': 'Warfarin-Steady-state milnacipran (200 mg/day) did not affect the pharmacokinetics of R-warfarin and S-warfarin or the pharmacodynamics (as assessed by measurement of prothrombin INR) of a single dose of 25 mg warfarin. The pharmacokinetics of Savella were not altered by warfarin. ', 'dose1': '200', 'dose2': '25', 'date': '2015-09-30 10:48:18 -0400', 'cmaxDirection': 'UNK', 'assertionType': 'DDI-clinical-trial', 'drug1Role': 'dikbD2R:object-drug-of-interaction', 'preciptFormulation': 'tablet', 'preciptDuration': 'Unk', 'objectDuration': '1', 'evidenceType': 'evidence-supports', 'preciptRegimens': 'Daily', 'cmax': 'Unk'}
{u'@id': 'urn:domeoclient:uuid:ecd18637-4e5c-4af1-82d7-1b6f0d9ff104',
 u'@type': u'ao:AnnotationSet',
 u'ao_!DOMEO_NS!_annotatesResource': 'http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/16a4a314-f97e-4e91-95e9-576a3773d284.html',
 u'ao_!DOMEO_NS!_item': [{u'@id': 'urn:domeoclient:uuid:829b453b-0383-4f86-9143-77d01e5917e0',
                          u'@type': u'ao:ddiAnnotation',
                          u'ao_!DOMEO_NS!_body': [{u'sets': {u'@id': 'urn:pddi:uuid:42792faa-fe87-45df-88f2-ae23689521f4',
                                                             u'@type': u'poc:DrugDrugInteractionStatement',
                                                             u'dikbD2R_!DOMEO_NS!_modality': 'ncit:negative',
                                                             u'dikbD2R_!DOMEO_NS!_statement': 'ncit:quantitative',
                                                             u'sio_!DOMEO_NS!_SIO_000205': u'dikbD2R:statement',
                                                             u'sio_!DOMEO_NS!_SIO_000563': u'dikbD2R:modality',
                                                             u'sio_!DOMEO_NS!_SIO_000628': [{u'@id': 'urn:pddi:uuid:2f6ec695-afd9-4eb9-bd4f-28ecc864dad8',
                                                                                             u'@type': u'dikbD2R:PK_DDI',
                                                                                             u'dikbD2R_!DOMEO_NS!_auc': 'Unk',
                                                                                             u'dikbD2R_!DOMEO_NS!_aucDirection': 'UNK',
                                                                                             u'dikbD2R_!DOMEO_NS!_aucType': 'UNK',
                                                                                             u'dikbD2R_!DOMEO_NS!_cl': 'Unk',
                                                                                             u'dikbD2R_!DOMEO_NS!_clDirection': 'UNK',
                                                                                             u'dikbD2R_!DOMEO_NS!_clType': 'UNK',
                                                                                             u'dikbD2R_!DOMEO_NS!_cmax': 'Unk',
                                                                                             u'dikbD2R_!DOMEO_NS!_cmaxDirection': 'UNK',
                                                                                             u'dikbD2R_!DOMEO_NS!_cmaxType': 'UNK',
                                                                                             u'dikbD2R_!DOMEO_NS!_numOfParticipants': 'Unk',
                                                                                             u'dikbD2R_!DOMEO_NS!_objectDuration': '1',
                                                                                             u'dikbD2R_!DOMEO_NS!_objectFormulation': 'tablet',
                                                                                             u'dikbD2R_!DOMEO_NS!_objectRegimens': 'SD',
                                                                                             u'dikbD2R_!DOMEO_NS!_preciptDuration': 'Unk',
                                                                                             u'dikbD2R_!DOMEO_NS!_preciptFormulation': 'tablet',
                                                                                             u'dikbD2R_!DOMEO_NS!_preciptRegimens': 'Daily',
                                                                                             u'dikbD2R_!DOMEO_NS!_t12': 'Unk',
                                                                                             u'dikbD2R_!DOMEO_NS!_t12Direction': 'UNK',
                                                                                             u'dikbD2R_!DOMEO_NS!_t12Type': 'UNK',
                                                                                             u'sio_!DOMEO_NS!_SIO_000132': [{u'@id': 'b753437e-6359-4ab6-9e15-6754588dd40b',
                                                                                                                             u'@type': 'dikbD2R:active-ingredient',
                                                                                                                             u'dailymed_!DOMEO_NS!_activeMoietyRxCUI': 'http://purl.bioontology.org/ontology/RXNORM/11289',
                                                                                                                             u'dct_!DOMEO_NS!_description': u'Referred to the drug in the interaction.',
                                                                                                                             u'dikbD2R_!DOMEO_NS!_dose': '200',
                                                                                                                             u'rdfs_!DOMEO_NS!_label': 'warfarin',
                                                                                                                             u'sio_!DOMEO_NS!_SIO_000228': 'dikbD2R:object-drug-of-interaction'},
                                                                                                                            {u'@id': '73aca42e-fe34-4dc1-9e07-804db0bdc13f',
                                                                                                                             u'@type': 'dikbD2R:active-ingredient',
                                                                                                                             u'dailymed_!DOMEO_NS!_activeMoietyRxCUI': 'http://purl.bioontology.org/ontology/RXNORM/',
                                                                                                                             u'dct_!DOMEO_NS!_description': u'Referred to the drug in the interaction.',
                                                                                                                             u'dikbD2R_!DOMEO_NS!_dose': '25',
                                                                                                                             u'rdfs_!DOMEO_NS!_label': 'milnacipran',
                                                                                                                             u'sio_!DOMEO_NS!_SIO_000228': 'dikbD2R:precipitant-drug-of-interaction'}]}]}}],
                          u'ao_!DOMEO_NS!_context': [{u'@id': 'urn:domeoclient:uuid:22de22c5-17b0-40a5-b5ce-2ea1512894c1',
                                                      u'@type': u'ao:SpecificResource',
                                                      u'ao_!DOMEO_NS!_hasSelector': {u'@id': 'urn:domeoclient:uuid:ad7d8e49-91ca-4451-b804-14067c93e3f8',
                                                                                     u'@type': u'ao:PrefixSuffixTextSelector',
                                                                                     u'ao_!DOMEO_NS!_exact': 'Warfarin-Steady-state milnacipran (200 mg/day) did not affect the pharmacokinetics of R-warfarin and S-warfarin or the pharmacodynamics (as assessed by measurement of prothrombin INR) of a single dose of 25 mg warfarin. The pharmacokinetics of Savella were not altered by warfarin. ',
                                                                                     u'ao_!DOMEO_NS!_prefix': 'pran and 150\xc2\xa0mg pregabalin .  ',
                                                                                     u'ao_!DOMEO_NS!_suffix': '',
                                                                                     u'domeo_!DOMEO_NS!_uuid': '2e20b258-24ba-4105-9b86-0aa68f95bc8b',
                                                                                     u'domeo_temp_localId': u'1',
                                                                                     u'pav_!DOMEO_NS!_createdOn': '2015-09-30 10:48:18 -0400'},
                                                      u'ao_!DOMEO_NS!_hasSource': 'http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/16a4a314-f97e-4e91-95e9-576a3773d284.html',
                                                      u'domeo_temp_localId': u'1'}],
                          u'dikbD2R_!DOMEO_NS!_assertionType': 'DDI-clinical-trial',
                          u'dikbD2R_!DOMEO_NS!_evidenceType': u'evidence-challenges',
                          u'domeo_!DOMEO_NS!_belongsToSet': 'urn:domeoclient:uuid:ecd18637-4e5c-4af1-82d7-1b6f0d9ff104',
                          u'pav_!DOMEO_NS!_createdBy': 'urn:person:uuid:ff808181508ae86901508ae930ec0000',
                          u'pav_!DOMEO_NS!_createdOn': '2015-09-30 10:48:18 -0400',
                          u'pav_!DOMEO_NS!_createdWith': u'urn:domeo:software:id:Domeo-2.0alpha-040',
                          u'pav_!DOMEO_NS!_lastSavedOn': '2015-09-30 10:48:18 -0400',
                          u'pav_!DOMEO_NS!_lineageUri': 'urn:domeoserver:annotation:793b5e5f-d82f-4920-8644-3eb759c9c5e5',
                          u'pav_!DOMEO_NS!_previousVersion': u'',
                          u'pav_!DOMEO_NS!_versionNumber': 1,
                          u'rdfs_!DOMEO_NS!_label': u'ddi Annotation'}],
 u'dct_!DOMEO_NS!_description': u'The default set is created automatically by Domeo when no other set is existing.',
 u'domeo_!DOMEO_NS!_agents': [{u'@id': 'urn:person:uuid:ff808181508ae86901508ae930ec0000',
                               u'@type': u'foafx:Person',
                               u'foafx_!DOMEO_NS!_email': u'admin@commonsemantics.org',
                               u'foafx_!DOMEO_NS!_firstname': u'Richard',
                               u'foafx_!DOMEO_NS!_homepage': u'',
                               u'foafx_!DOMEO_NS!_lastname': u'Boyce',
                               u'foafx_!DOMEO_NS!_middlename': u'',
                               u'foafx_!DOMEO_NS!_name': u'Dr. Boyce',
                               u'foafx_!DOMEO_NS!_picture': u'http://www.hcklab.org/images/me/paolo%20ciccarese-boston.jpg',
                               u'foafx_!DOMEO_NS!_title': u'',
                               u'rdfs_!DOMEO_NS!_label': u'Dr. Boyce'},
                              {u'@id': u'urn:domeo:software:id:Domeo-2.0alpha-040',
                               u'@type': u'foafx:Software',
                               u'foafx_!DOMEO_NS!_build': u'040',
                               u'foafx_!DOMEO_NS!_homepage': u'',
                               u'foafx_!DOMEO_NS!_name': u'Domeo Annotation Toolkit',
                               u'foafx_!DOMEO_NS!_version': u'2.0alpha',
                               u'rdfs_!DOMEO_NS!_label': u'Domeo Annotation Toolkit'}],
 u'domeo_!DOMEO_NS!_deleted': u'false',
 u'domeo_!DOMEO_NS!_resources': [{u'label': u'DailyMed - PAROXETINE - paroxetine hydrochloride hemihydrate tablet, film coated',
                                  u'url': 'http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/16a4a314-f97e-4e91-95e9-576a3773d284.html'}],
 u'pav_!DOMEO_NS!_createdBy': 'urn:person:uuid:ff808181508ae86901508ae930ec0000',
 u'pav_!DOMEO_NS!_createdOn': '2015-09-30 10:48:18 -0400',
 u'pav_!DOMEO_NS!_createdWith': u'urn:domeo:software:id:Domeo-2.0alpha-040',
 u'pav_!DOMEO_NS!_lastSavedOn': '2015-09-30 10:48:18 -0400',
 u'pav_!DOMEO_NS!_lineageUri': 'urn:domeoserver:annotationset:c844a449-4cf8-449c-9b68-9ccf81a93092',
 u'pav_!DOMEO_NS!_previousVersion': u'urn:domeoclient:uuid:F5307257-D84B-4C3E-973B-289ABAAE53DE',
 u'pav_!DOMEO_NS!_versionNumber': 1,
 u'permissions_!DOMEO_NS!_permissions': {u'permissions_!DOMEO_NS!_accessType': u'urn:domeo:access:public',
                                         u'permissions_!DOMEO_NS!_isLocked': u'false'},
 u'rdfs_!DOMEO_NS!_label': u'Default Set'}
load annotations for http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/16a4a314-f97e-4e91-95e9-576a3773d284.html
